<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A Versatile Chemo-Enzymatic Route to Enantiomerically Pure β-Branched-α-Amino Acids</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Geoffrey</forename><forename type="middle">J</forename><surname>Roff</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Chemistry</orgName>
								<orgName type="institution">University of Edinburgh</orgName>
								<address>
									<addrLine>King&apos;s Buildings West Mains Road</addrLine>
									<postCode>EH9 3JJ</postCode>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Richard</forename><forename type="middle">C</forename><surname>Lloyd</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Chirotech Technology Ltd</orgName>
								<address>
									<settlement>Dowpharma</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicholas</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Chemistry</orgName>
								<orgName type="institution">University of Edinburgh</orgName>
								<address>
									<addrLine>King&apos;s Buildings West Mains Road</addrLine>
									<postCode>EH9 3JJ</postCode>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">The Dow Chemical Company</orgName>
								<address>
									<addrLine>Unit 321 Cambridge Science Park Milton Road</addrLine>
									<postCode>CB4 0WG</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">A Versatile Chemo-Enzymatic Route to Enantiomerically Pure β-Branched-α-Amino Acids</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">10D6EBC7995F7EDEBAC778E363837F26</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-24T14:54+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=0, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[0], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>IR absorption spectra were recorded on a Jasco-FT/IR-410 Spectrophotometer using standard techniques. 1 H and 13 C-NMR spectra were recorded on a Varian Gemini or Bruker AC250 spectrometer. Chemical shifts are reported in ppm.</p><p>Mass spectra were recorded on a Micromass Platform-2 under electrospray conditions or Magnetic Sector MS250 machine for FAB-MS.</p><p>Analytical normal phase HPLC was performed on a Chiracel OD-H column eluting with 1ml/min 5% IPA in Hexane at 210nm at 10°C. Reverse phase HPLC was performed on a Chirobiotic T column eluting with 0.7ml/min 40% ethanol in Water at 210nm. Peak intensities are reported to an accuracy of 0.1%.</p><p>Optical rotation was measured on an AA1000 polarimeter from Optical Activity Ltd (measurements made at the sodium D-line). Concentrations are given in g/100ml.</p><p>Column chromatography was carried out using Fisher silica 60A, particle size 35-70 micron).</p><p>Melting points were carried out on a Gallenkamp melting point apparatus with no corrections.</p><p>All solvents and reagents are standard laboratory grade and were obtained from commercial sources. The Trigonopsis variabilis D-amino acid oxidase was obtained from Sandoz. The porcine kidney D-amino acid oxidase and snake venom L-amino acid oxidase were obtained from Sigma.</p><p>1) Synthesis of (Z)-2-Acetylamino-3-iodo-but-2-enoic acid methyl ester 5 AcHN CO 2 Me I Me NIS (12.9g, 0.057mol) was added to a stirring solution of methyl 2-(N-acetylamino)-Z-butenoate 3 (7.50g, 0.048mol) in 2% TFA in CH 2 Cl 2 (250ml with 5ml TFA). The mixture was stirred at room temperature overnight. The mixture was cooled in an ice bath before triethylamine (20ml) was added slowly. The mixture was allowed to stir for a further hour. The mixture was concentrated and taken up in CH 2 Cl 2 , washed with 1M KHSO 4 , water and brine before concentrating and running down a column of silica (CH 2 Cl 2 /ethyl acetate 1:1) to obtain 5 as a yellow/brown solid (5.41g, 40%). ν max (KBr) 1518 (NH bend),1659 (C=O amide), 1717 (C=O ester), 3249 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 2.15 (3H, s, CH 3 ), 2.80(3H, s, Ac), 3.84 (3H, s, CO 2 CH 3 ), 6.91(1H,s br., NH); δ C (63MHz, CDCl 3 ) 22.7 (CH 3 ), 28.8 (Ac), 52.5 (CO 2 CH 3 ), 102.1, 131.4, 161.4, 168.1 (C); m/z (FAB) 284 (MH + ); found (FAB) 283.97830 (MH + ), C 7 H 11 INO 3 requires 283.97837.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2) General procedure for Suzuki couplings</head><p>A mixture of vinyl iodide 5, boronic acid, palladium acetate and sodium carbonate in ethanol was heated at 55°C for 4 hours.</p><p>The mixture was concentrated and taken up in CH 2 Cl 2 /water (1:1). The CH 2 Cl 2 layer was further washed once with water, once with brine and dried over MgSO 4 before concentrating to the crude product. Column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave the pure product.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.1) Synthesis of (Z)-2-Acetylamino-3-phenyl-but-2-enoic acid methyl ester 6a</head><p>AcHN CO 2 Me</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Me</head><p>The general procedure was followed using vinyl iodide 5 (400mg, 1.41mmol), phenylboronic acid (259mg, 2.12mmol), palladium acetate (32mg, 0.141mmol), sodium carbonate (300mg, 2.83mmol) and ethanol (15ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1 gave 6a as a white solid (265mg, 81%).</p><p>ν max (nujol) 1532 (N-H bend), 1657 (C=O amide), 1720 (C=O ester), 3177cm -1 (N-H stretch); δ H (200MHz, CDCl 3 ) 1.85 (3H, s, CH 3 ), 2.24 (3H, s, Ac), 3.80 (3H, s, CO 2 CH 3 ), 6.56 (1H, s br., NH), 7.32-7.41 (5H, m, ArH); δ C (63MHz, CDCl 3 ) 20.5 (CH 3 ), 22.4 (Ac), 52.0 (CO 2 CH 3 ), 127.2, 128.0, 128.7 (C Ar ), 123.5, 137.5, 139.8, 165.5, 168.6 (C); m/z (FAB) 234 (MH + ); found (FAB) (MH + ) 234.11316; C 13 H 16 NO 3 requires 234.11302; TLC 0.27 (CH 2 Cl 2 / ethyl acetate 1:1). 2.2) Synthesis of (Z)-2-Acetylamino-3-(4-fluorophenyl)but-2-enoic acid methyl ester 6b AcHN CO 2 Me Me F</p><p>The general procedure was followed using vinyl iodide 5 (500mg, 1.77mmol), 4-fluorophenylboronic acid (371mg, 2.65mmol), palladium acetate (40mg, 0.177mmol), sodium carbonate (375mg, 3.53mmol) and ethanol (15ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave 6b as a white solid (341mg, 77%).</p><p>KBr) 1509 (NH bend),1654 (C=O amide), 1723 (C=O ester), 3280 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 2.09 (3H, s, CH 3 ), 2.45 (3H, s, Ac), 4.02 (3H, s, CO 2 CH 3 ), 6.70 (1H,s br., NH), 7.23-7.46 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 21.2 (CH 3 ), 23.0 (Ac), 52.6 (CO 2 CH 3 ), 116.1, 116.4,129.6, 129.7 (C Ar ), 124.2, 236.3, 137.9, 164.7, 165.9, 169.1 (C); m/z (FAB) 25 2(MH + ); found (FAB) 252.10362 (MH + ), C 13 H 15 FNO 3 requires 252.10360. 2.3) Synthesis of (Z)-2-Acetylamino-3-(4-trifluoromethylphenyl)but-2-enoic acid methyl ester 6c AcHN CO 2 Me Me F 3 C</p><p>The general procedure was followed using vinyl iodide 5 (400mg, 1.41mmol), 4-trifluoromethylphenylboronic acid (403mg, 2.12mmol), palladium acetate (32mg, 0.141mmol), sodium carbonate (300mg, 2.83mmol) and ethanol (15ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave 6c as a white solid (356mg, 84%). ν max (KBr) 1508 (NH bend),1682 (C=O amide), 1709 (C=O ester), 3306 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.96 (3H, s, CH 3 ), 2.36 (3H, s ,Ac), 3.90 (3H, s, CO 2 CH 3 ), 6.57 (1H, s br., NH), 7.33-7.73 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 20.4 (CH 3 ), 22.5 (Ac), 52.2 (CO 2 CH 3 ), 125.7, 127.7 (C Ar ), 124.2, 137.4, 143.8, 165.1, 168.7 (C); m/z (FAB) 302 (MH + ); found (FAB) 302.10071 (MH + ), C 14 H 15 F 3 NO 3 requires 302.10040.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.4) Synthesis of (Z)-2-Acetylamino-3-naphthalen-2-yl-but-2-enoic acid methyl ester 6d</head><p>AcHN CO 2 Me</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Me</head><p>The general procedure was followed using vinyl iodide 5 (800mg, 2.82mmol), 2-naphthaleneboronic acid (729mg, 4.24mmol), palladium acetate (64mg, 0.242mmol), sodium carbonate (600mg, 5.66mmol) and ethanol (25ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave 6d as a pale yellow solid (575mg, 72%).</p><p>ν max (KBr) 1509 (NH bend),1650 (C=O amide), 1720 (C=O ester), 3298 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.78 (3H, s, CH 3 ), 2.28 (3H, s, Ac), 3.77 (3H, s, CO 2 CH 3 ), 6.52 (1H, s br., NH), 7.28-7.80 (7H, m, ArH); δ C (63MHz,CDCl 3 )</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>20.5 (CH 3 ), 22.4 (Ac), 52.1 (CO 2 CH 3 ), <ref type="bibr">125.2,</ref><ref type="bibr">126.4,</ref><ref type="bibr">126.5,</ref><ref type="bibr">127.6,</ref><ref type="bibr">127.9,</ref><ref type="bibr">128.5 (C Ar ),</ref><ref type="bibr">123.9,</ref><ref type="bibr">132.7,</ref><ref type="bibr">133.1,</ref><ref type="bibr">137.2,</ref><ref type="bibr">137.3,</ref><ref type="bibr">165.5,</ref><ref type="bibr">168.6 (C)</ref>; m/z (FAB) 284 (MH + ); found (FAB) 284.12934 (MH + ), C 17 H 18 NO 3 requires 284.12867.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.5) Synthesis of (Z)-2-Acetylamino-3-(3,5-dimethylphenyl)but-2-enoic acid methyl ester 6e</head><p>AcHN CO 2 Me Me Me</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Me</head><p>The general procedure was followed using vinyl iodide 5 (400mg, 1.41mmol), 3,5-dimethylphenylboronic acid (318mg, 2.12mmol), palladium acetate (32mg, 0.141mmol), sodium carbonate (300mg, 2.83mmol) and ethanol (15ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave 6e as a white solid (301mg, 82%).</p><p>ν max (KBr) 1527 (NH bend),1648 (C=O amide), 1728 (C=O ester), 3238 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 2.08 (3H, s, CH 3 ), 2.40 (3H, s, Ac), 2.50 (6H, s, (CH 3 ) 2 ), 6.71 (1H, s br., NH), 7.14-7.27 (3H, m, ArH); δ C (63MHz, CDCl 3 ) 20.4 (CH 3 ), 21.1 ((CH 3 ) 2 ), 22.5 (Ac), 52.0 (CO 2 CH 3 ), 124.8, 129.7 (C Ar ), <ref type="bibr">123.4, 136.9, 138.4, 139.6, 165.5, 168.4 (C)</ref>; m/z (FAB) 262 (MH + ); (FAB) Found 262.14480 (MH + ), C 15 H 20 NO 3 requires 267.14432.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.6) Synthesis of (Z)-2-Acetylamino-3-(4-methoxyphenyl)but-2-enoic acid methyl ester 6f</head><p>AcHN CO 2 Me</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Me</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MeO</head><p>The general procedure was followed using vinyl iodide 5 (500mg, 1.77mmol), 4-methoxyphenylboronic acid (403mg, 2.65mmol), palladium acetate (40mg, 0.177mmol), sodium carbonate (375mg, 3.53mmol) and ethanol (15ml).</p><p>Wet flash column chromatography (CH 2 Cl 2 /ethyl acetate 1:1) gave 6f a white solid (338mg, 73%).</p><p>ν max (KBr) 1519 (NH bend),1637 (C=O amide), 1720 (C=O ester), 3244 cm -1 (NH stretch); δ H (200MHz, CDCl 3 ) 1.99 (3H, s, CH 3 ), 2.32 (3H, s, Ac), 3.91 (3H, s, CO 2 CH 3 ), 6.55 (1H, s br., NH), 6.97-7.34 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 20.5 (CH 3 ), 22.5 (Ac), 52.0 (CO 2 CH 3 ), 55.1 (OCH 3 ), 114.0, 128.7 (C Ar ), <ref type="bibr">123.2, 131.7, 137.4, 159.3, 165.7, 168.6 (C)</ref>; m/z (FAB) 264 (MH + ); found (FAB) 264.12316 (MH + ), C 14 H 18 NO 4 requires 264.12358.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3) General procedure for asymmetric hydrogenations</head><p>A mixture of didehydroamino acid Z-6 and either [Rh(R,R)-Et-DuPhos(COD)]BF 4 or [Rh(S,S)-Et-DuPhos(COD)]BF 4 (1 mol%) were stirred in degassed methanol under 100psi of hydrogen. The mixture was concentrated and run down a short column (EtOAc) of silica to yield the pure product.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.1) Synthesis of (2R,3S</head><p>)-2-Acetylamino-3-phenyl-butyric acid methyl ester (2R,3S)-7a</p><p>AcHN CO 2 Me Me H H The general procedure was followed using alkene 6a (300mg, 1.29mmol), [Rh(R,R)-Et-DuPhos(COD)]BF 4 (8.4mg, 0.013mmol)) and methanol (5ml) at 100psi for 72 hours. Work up yielded (2R,3S)-7a as a white solid (300mg, 99%). M.p. 82-86°C; ν max (Film) 1541 (NH bend), 1657 (C=O amide), 1743 (C=O ester) , 3289 cm -1 (NH stretch); (200MHz, CDCl 3 ) 1.47 (3H, d J=7.4Hz, CH 3 ), 2.06 (3H, s, COCH 3 ), 3.25 (1H, quin. J=7.0Hz, CH), 3.62 (3H, s, CO 2 CH 3 ), 4.87 (1H, dd J=6.6&amp;9.0Hz, CH), 6.20 (1H, d br. J= 8.6Hz, NH), 7.21-7.41 (5H, m, ArH); m/z (ES + ) 236 (MH + ); [α] 21 D -47.4° (c=0.27, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 16.34 (99.3%), 20.22 (0.7%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.2) Synthesis of (2R,3S)-2-Acetylamino-3-(4-fluorophenyl)butyric acid methyl ester (2R,3S)-7b</head><p>AcHN CO 2 Me Me H H F</p><p>The general procedure was followed using alkene 6b (300mg, 1.20mmol), [Rh(R,R)-Et-DuPhos(COD)]BF 4 (7.9mg, 0.012mmol) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2R,3S)-7b as a pale yellow solid (300mg, 99%</p><p>). M.p. 92-95°C; ν max (KBr) 1512 (NH bend), 1652 (C=O amide), 1738 (C=O ester) , 3316cm -1 (NH stretch); δ H (250MHz,CDCl 3 ) 1.28 (3H, d J=7.2Hz, CH 3 ), 1.94 (3H, s, Ac), 3.14 (1H, quin. J=7.1Hz, CH), 3.50 (3H, s, CO 2 CH 3 ), 4.71 (1H, dd J=6.7 &amp; 8.9Hz, CH), 6.00(1H, d br. J=8.8Hz, NH) 6.87-7.20 (4H, m, ArH); δ C (63MHz,CDCl 3 ) 17.5 (CH 3 ), 23.5 (Ac), 42.4 (CH), 52.5 (CO 2 CH 3 ), 57.9 (CH), 115.4, 115.8, 129.4, 129.5 (C Ar ), 137.2, 160.3, 164.2, 170.0, 172.3 (C); m/z (FAB) 254 (MH + ); found (FAB) 254.11962 (MH + ), C 13 H 17 FNO 3 requires 254.11925. HPLC: Chiracel OD-H; R t (min) 17.49 (99.0%), 27.05 (0.1%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.3) Synthesis of (2R,3S)-2-Acetylamino-3-(4-trifluoromethylphenyl)butyric acid methyl ester (2R,3S)-7c</head><p>The general procedure was followed using alkene 6c (300mg, 1.00mmol), (R,R)-EtDuPhos (6.6mg, 0.010mmol) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2R,3S)-7c as a white solid (300mg, 99%</p><p>). M.p. 75-77 °C ;ν max (KBr) 1564 (NH bend), 1654 (C=O amide), 1741 (C=O ester), 3318cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.32 (3H, d J=7.2Hz, CH 3 ), 1.94 (3H, s, Ac), 3.22 (1H, quin. J=7.1Hz, CH), 3.51 (3H, s, CO 2 CH 3 ), 4.78 (1H, dd J=6.6 &amp; 8.8Hz, CH), 6.01 (1H, d br. J=8.4Hz, NH), 7.20-7.50 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 16.7 (CH 3 ), 23.0 (Ac), 42.5 (CH), 52.1 (CO 2 CH 3 ), 57.1 (CH), 125.2, 127.9 (C Ar ), 145.2, 169.6, 171.5 (C); m/z (FAB) 304 (MH + ); found (FAB) 304.11621 (MH + ), C 14 H 17 F 3 NO 3 requires 304.11605; [α] 21 D -49.5° (c=0.63, CHCl 3 ). 3.4) Synthesis of (2R,3S)-2-Acetylamino-3-naphthalen-2-yl-butyric acid methyl ester (2R,3S)-7d AcHN CO 2 Me Me H H The general procedure was followed using alkene 6d (300mg, 0.99mmol), [Rh(R,R)-Et-DuPhos(COD)]BF 4 (6.5mg, 0.010mmol) and methanol (5ml) at 100psi for 72 hours. Workup yielded (2R,3S)-7d as a pale yellow solid (300mg, 99%). M.p. 65-69°C; ν max (KBr) 1544 (NH bend), 1639 (C=O amide), 1739 (C=O ester) , 3267cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.40 (3H, d J=7.2Hz, CH 3 ), 1.91( 3H, s, Ac), 3.28 (1H, quin. J=7.1Hz, CH), 3.44 (3H,s, CO 2 CH 3 ), 4.83 (1H, dd J=6.9 &amp; 8.9Hz, CH), 6.01 (1H, d br. J=8.6Hz, NH), 7.18-7.74 (7H, m, ArH); δ C (63MHz, CDCl 3 ) 16.5 (CH 3 ), 22.4 (Ac), 42.2 (CH), 51.3 (CO 2 CH 3 ), 56.9 (CH), 125.0, 125.1, 125.4, 125.7, 127.0, 127.4 (C Ar ), 131.9, 132.4, 138.0, 169.1, 171.4 (C); m/z (FAB) 286 (MH + ); found (FAB) 286.14219 (MH + ), C 17 H 20 NO 3 requires 286.14432; [α] 21 D -58.4° (c=0.69, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 21.08 (99.7%), 26.62 (0.3%). 3.5) Synthesis of (2R,3S)-2-Acetylamino-3-(3,5-dimethylphenyl)butyric acid methyl ester (2R,3S)-7e AcHN CO 2 Me Me H H Me Me The general procedure was followed using alkene 6e (300mg, 1.14mmol), [Rh(R,R)-Et-DuPhos(COD)]BF 4 (7.6mg, 0.011mmol) and methanol (5ml) at 100psi for 72 hours. Workup yielded (2R,3S)-7e as a pale yellow solid (300mg, 99%). M.p. 115-118°C; ν max (KBr) 1540 (NH bend), 1650 (C=O amide), 1739 (C=O ester) , 3320 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.29 (3H, d J=7.2Hz, CH 3 ), 1.92 (3H, s, Ac), 2.17 (6H, s, (CH 3 ) 2 ), 3.03 (1H, quin. J=7.1Hz, CH), 3.49 (3H, s, CO 2 CH 3 ), 4.69 (1H, dd J=6.8 &amp; 8.9Hz, CH), 6.00 (1H, s br. J=8.8Hz, NH), 6.69-6.80 (3H, m, ArH); (63MHz, CDCl 3 ) 16.9 (CH 3 ), 21.2 ((CH 3 ) 2 ), 23.0 (Ac), 42.4 (CH), 51.7 (CO 2 CH 3 ), 57.5 (CH), 125.3, 137.6 (C Ar ), 128.7, 140.8, 169.5, 171.9 (C); (FAB) 264 (MH + ); found (FAB) 264.15971 (MH + ), C 15 H 22 NO 3 requires 264.15997; [α] 21 D -75.7° (c=0.44, CHCl 3 ). 3.6) Synthesis of (2R,3S)-2-Acetylamino-3-(4-methoxyphenyl)butyric acid methyl ester (2R,3S)-7f AcHN CO 2 Me Me H H MeO The general procedure was followed using alkene 6f (300mg, 1.14mmol), [Rh(R,R)-Et-DuPhos(COD)]BF 4 (7.5mg, 0.011mmol) and methanol (5ml) at 100psi for 72 hours. Workup yielded (2R,3S)-7f as a pale yellow solid (300mg, 99%). M.p. 101-105°C; ν max (KBr) 1514 (NH bend), 1650 (C=O amide), 1738 (C=O ester) , 3252 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.29 (3H, d J=7.2Hz, CH 3 ), 1.93 (3H, s, Ac), 3.07 (1H, quin. J=7.1Hz, CH), 3.50 (3H, s, CO 2 CH 3 ), 3.79 (3H, s, OCH 3 ), 4.69 (1H, dd J=6.7 &amp; 8.8Hz, CH), 6.02 (1H, d br. J=9.0Hz, NH), 6.69-7.03 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 16.6 (CH 3 ), 22.5 (Ac), 41.3 (CH), 51.3 (CO 2 CH 3 ), 54.5 (OCH 3 ), 57.1 (CH), 113.1, 127.9 (C Ar ), 132.4, 158.0, 169.0, 171.4 (C); m/z (FAB) 266 (MH + ); found (FAB) 266.13870 (MH + ), C 14 H 20 NO 4 requires 266.13923; [α] 21 D -48.0° (c=0.32, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 21.36 (98.0%), 27.71 (2.0%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.7) Synthesis of (2S,3R)-2-Acetylamino-3-phenyl-butyric acid methyl ester (2S,3R)-7a</head><p>AcHN CO 2 Me Me H H The general procedure was followed using alkene 6a (300mg, 1.29mmol), [Rh(S,S)-Et-DuPhos(COD)]BF 4 (8.4mg, 0.013mmol)) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2S,3R)-7a as a white solid (300mg, 99%</p><p>). M.p. 81-84°C; ν max (Film) 1544 (NH bend), 1657 (C=O amide), 1744 (C=O ester), 3285 cm -1 (NH stretch); δ H (200MHz, CDCl 3 ) 1.47 (3H, d J=7.4Hz, CH 3 ), 2.06 (3H, s, COCH 3 ), 3.25 (1H, quin. J=7.0Hz, CH), 3.62 (3H, s, CO 2 CH 3 ), 4.87 (1H, dd J=6.6&amp;9.0Hz, CH), 6.20 (1H, d br. J= 8.6Hz, NH), 7.21-7.41 (5H, m, ArH); m/z (ES + ) 236 (MH + ); [α] 21 D +49.3° (c=0.14, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 15.25 (0.1%), 15.25 (99.9%). 3.8) Synthesis of (2S,3R)-2-Acetylamino-3-(4-fluorophenyl)butyric acid methyl ester (2S,3R)-7b AcHN CO 2 Me Me H H F</p><p>The general procedure was followed using alkene 6b (300mg, 1.20mmol), (S,S)-EtDuPhos (7.9mg, 0.012mmol) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2S,3R)-7b as a pale yellow solid (300mg, 99%</p><p>). M.p. 92-94°C; ν max (KBr) 1511 (NH bend), 1651 (C=O amide), 1738 (C=O ester) , 3316 cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.28 (3H, d J=7.2Hz, CH 3 ), 1.94 (3H, s, Ac), 3.14(1H, quin. J=7.1Hz, CH), 3.50 (3H, s, CO 2 CH 3 ), 4.71 (1H, dd J=6.7 &amp;8.9Hz, CH), 6.00 (1H, d br. J=8.8Hz, NH) 6.87-7.20 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 17.5 (CH3), 23.5 (Ac), 42.4 (CH), 52.5 (CO 2 CH 3 ), 57.9 (CH), 115.4, 115.8, 129.4, 129.5 (C Ar ), 137.2, 160.3, 164.2, 170.0, 172.3 (C); m/z (FAB) 254 (MH + ); found (FAB) 254.11925 (MH + ), C 13 H 17 FNO 3 requires 254.11925. HPLC: Chiracel OD-H; R t (min) 26.08% (100%). 3.9) Synthesis of (2S,3R)-2-Acetylamino-3-(4-trifluoromethylphenyl)butyric acid methyl ester (2S,3R)-7c AcHN CO 2 Me Me H H F 3 C</p><p>The general procedure was followed using alkene 6c (300mg, 1.00mmol), [Rh(S,S)-Et-DuPhos(COD)]BF 4 (6.6mg, 0.010mmol) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2S,3R)-7c as a white solid (300mg, 99%</p><p>). M.p. 73-75°C; ν max (KBr) 1538 (NH bend), 1653 (C=O amide), 1741 (C=O ester) , 3317cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.32 (3H, d J=7.2Hz, CH 3 ), 1.94 (3H, s, Ac), 3.22 (1H, quin. J=7.1Hz, CH), 3.51 (3H, s, CO 2 CH 3 ), 4.78 (1H, dd J=6.6 &amp; 8.8Hz, CH), 6.01(1H, d br. J=8.4Hz, NH), 7.20-7.50 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 16.7 (CH 3 ), 23.0 (Ac), 42.5 (CH), 52.1 (CO 2 CH 3 ), 57.1 (CH), 125.2, 127.9 (C Ar ), 145.2, 169.6, 171.5 (C); m/z (FAB) 304 (MH + ); found (FAB) 304.11558 (MH + ), C 14 H 17 F 3 NO 3 requires 304.11605; [α] 21 D +41.7° (c=0.79, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 17.00 (0.9%), 20.37 (99.1%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.10) Synthesis of (2S,3R)-2-Acetylamino-3-naphthalen-2-yl-butyric acid methyl ester (2S,3R)-7d</head><p>The general procedure was followed using alkene 6d (300mg, 0.99mmol), [Rh(S,S)-Et-DuPhos(COD)]BF 4 (6.5mg, 0.010mmol) and methanol (5ml) at 100psi for 72 hours.</p><p>Workup yielded (2S,3R)-7d as a pale yellow solid (300mg, 99%). M.p. 70-72 °C; ν max (KBr) 1544 (NH bend), 1639 (C=O amide), 1738 (C=O ester), 3266cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.40 (3H, d J=7.2Hz, CH 3 ), 1.91 (3H, s, Ac), 3.28 (1H, quin. J=7.1Hz, CH), 3.44 (3H, s, CO 2 CH 3 ), 4.83 (1H, dd J=6.9 &amp; 8.9Hz, CH), 6.01 (1H, d br. J=8.6Hz, NH), 7.18-7.74 (7H, m, ArH); δ C (63MHz, CDCl 3 ) 16.5 (CH3), 22.4 (Ac), 42.2 (CH), 51.3 (CO 2 CH 3 ), 56.9 (CH), <ref type="bibr">125.0, 125.1, 125.4, 125.7, 127.0, 127.4</ref> (C Ar ), 131.9, 132.4, 138.0, 169.1, 171.4 (C); m/z (FAB) 286 (MH + ); found (FAB) 286.14475 (MH + ), C 17 H 20 NO 3 requires 286.14432; [α] 21 D +50.5° (c=0.83, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 22.09 (0.9%), 25.09 (99.1%). 3.11) Synthesis of (2S,3R)-2-Acetylamino-3-(3,5-dimethylphenyl)butyric acid methyl (2S,3R)-7e AcHN CO 2 Me Me H H Me Me The general procedure was followed using alkene 6e (300mg, 1.14mmol), [Rh(S,S)-Et-DuPhos(COD)]BF 4 (7.6mg, 0.011mmol) and methanol (5ml) at 100psi for 72 hours. Workup yielded (2S,3R)-7e as a pale yellow solid (300mg, 99%). M.p. 112-114°C; ν max (KBr) 1541 (NH bend), 1650 (C=O amide), 1740 (C=O ester), 3319cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.29 (3H, d J=7.2Hz, CH 3 ), 1.92 (3H, s, Ac), 2.17 (6H, s, (CH 3 ) 2 ), 3.03 (1H, quin. J=7.1Hz, CH), 3.49 (3H, s, CO 2 CH 3 ), 4.69 (1H,dd J=6.8 &amp; 8.9Hz, CH), 6.00 (1H, s br. J=8.8Hz, NH), 6.69-6.80 (3H, m, ArH); δ C (63MHz, CDCl 3 ) 16.9 (CH 3 ), 21.2 ((CH 3 ) 2 ), 23.0 (Ac), 42.4 (CH), 51.7 (CO 2 CH 3 ), 57.5 (CH), 125.3, 137.6 (C Ar ), 128.7, 140.8, 169.5, 171.9 (C); (FAB) 264 (MH + ); found (FAB) 264.15971 (MH + ), C 15 H 22 NO 3 requires 264.15997; [α] 21 D +71.6° (c=0.71, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 18.93 (100%). 3.12) Synthesis of (2S,3R)-2-Acetylamino-3-(4-methoxyphenyl)butyric acid methyl ester (2S,3R)-7f AcHN CO 2 Me Me H H MeO The general procedure was followed using alkene 6f (300mg, 1.14mmol), [Rh(S,S)-Et-DuPhos(COD)]BF 4 (7.5mg, 0.011mmol) and methanol (5ml) at 100psi for 72 hours. Workup yielded (2S,3R)-7f as a pale yellow solid (300mg, 99%). M.p. 108-110°C; ν max (KBr) 1514 (NH bend), 1650 (C=O amide), 1738 (C=O ester) , 3252cm -1 (NH stretch); δ H (250MHz, CDCl 3 ) 1.29 (3H, d J=7.2Hz, CH3), 1.93 (3H, s, Ac), 3.07 (1H, quin. J=7.1Hz, CH), 3.50 (3H, s, CO 2 CH 3 ), 3.79 (3H, s, OCH 3 ), 4.69 (1H, dd J=6.7 &amp; 8.8Hz, CH), 6.02 (1H, d br. J=9.0Hz, NH), 6.69-7.03 (4H, m, ArH); δ C (63MHz, CDCl 3 ) 16.6 (CH 3 ), 22.5 (Ac), 41.3 (CH), 51.3 (CO 2 CH 3 ), 54.5 (OCH 3 ), 57.1 (CH), 113.1, 127.9 (C Ar ), 132.4, 158.0, 169.0, 171.4 (C); m/z (FAB) 266 (MH + ); found (FAB) 266.13926 (MH + ), C 14 H 20 NO 4 requires 266.13923; [α] 21 D +45.0° (c=0.38, CHCl 3 ). HPLC: Chiracel OD-H; R t (min) 22.52 (3.3%), 26.34 (96.7%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4) General procedure for hydrolysis</head><p>HCl (4N, 20ml) was added to a stirring solution of protected amino acid 7 (250mg) in acetone (2.5ml) and the mixture was heated under reflux for 3 hours. The mixture as treated with decolourising charcoal before filtering and concentrating. Trituration with acetone gave the pure product.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.1) Synthesis of (2R,3S</head><p>)-2-Amino-3-phenyl-butyric acid hydrochloride (2R,3S)-1a</p><formula xml:id="formula_0">H 2 N CO 2 H Me H H HCl</formula><p>The general procedure was followed using (2R,3S)-7a (250mg,1.06mmol), acetone (2.5ml) and HCl (20ml) and yielded (2R,3S)-1a as a white solid (201mg, 88%</p><p>). M.p. 195-198°C; ν max (nujol) 1603 (amino acid II), 1731 (amino acid I), 1951 and 2535 (NH 3 + overtones and combinations), 2975 (OH), 3437cm -1 (NH 3 + ); δ H (250MHz, D 2 O) 1.29 (3H, d J=7.3Hz, CH 3 ), 3.80 (1H, m, J=5.9Hz, CH), 4.70 (1H, d J=5.7Hz, CH), 7.16-7.40 (5H, m, ArH); δ C (63MHz, D 2 O) 15.1 (CH 3 ), 40.1 (CH), 59.2 (CH), 128.2, 128.5, 129.6 (C Ar ), 139.5 171.6 (C); m/z (FAB) 180 (MH + ); found (FAB) 180.10245 (MH + ), C 10 H 14 NO 2 requires 180.10245; [α] 22 D -5.0° (c=0.50, H 2 O). HPLC: Chirobiotic T; R t (min) 7.69 (0.2%), 9.55 (99.8%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.2) Synthesis of (2R,3S)-2-Amino-3-(4-fluorophenyl)butyric acid hydrochloride (2R,3S)-1b</head><formula xml:id="formula_1">H 2 N CO 2 H Me H H HCl F</formula><p>The general procedure was followed using (2R,3S)-7b (253mg, 1.0mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2R,3S)-1b as a white solid (181mg, 78%</p><p>). M.p. 190-192°C; ν max (KBr) 1605 (amino acid II), 1732 (amino acid I), 2531 (NH 3 + overtones and combinations), 2992 (OH), 3448cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.38 (3H, d J=7.2Hz, CH 3 ), 3.49 (1H, quin. J=6.2Hz, CH), 4.17 (1H, d J=5.8Hz, CH), 7.05-7.34 (4H, m, ArH); δ C (63MHz, D 2 O) 15.5 (CH 3 ), 39.5 (CH), 59.2 (CH), 116.0, 116.4, 129.9, 130.1 (C Ar ), 135.3, 160.6, 164.5, 171.5 (C); m/z (FAB) 198 (MH + ); found (FAB) 198.09337 (MH+), C 10 H 13 FNO 2 requires 198.09303; [α] 22 D -4.5° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 7.85 (0.3%), 9.21 (99.7%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.3) Synthesis of (2R,3S)-2-Amino-3-(4-trifluoromethylphenyl)butyric acid hydrochloride (2R,3S)-1c</head><formula xml:id="formula_2">H 2 N CO 2 H Me H H HCl F 3 C</formula><p>The general procedure was followed using (2R,3S)-7c (250mg, 0.83mmol), acetone (2.5ml) and HCl (20.0ml) and ether trituration yielded (2R,3S)-1c as a white solid (168mg, 71%</p><p>). M.p. 183-186°C; ν max (KBr) 1623 (amino acid II), 1733 (amino acid I), 2998 (OH), 3443cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.36(3H, d J=6.8Hz, CH 3 ), 3.51(1H, quin. J=6.2Hz, CH), 4.07 (1H, d J=6.0Hz, CH), 7.41-7.67 (4H, m, ArH); δ C (63MHz, D 2 O) 15.3 (CH 3 ), 40.1 (CH), 58.9 (CH), 126.7, 128.8 (C Ar ), 143.9, 171.3 (C); m/z (FAB) 248 (MH + ); found (FAB) 248.09024 (MH + ), C 11 H 13 F 3 NO 2 requires 248.08984; [α] 22 D -6.0 ° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 11.06 (100%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.4) Synthesis of (2R,3S)-2-Amino-3-naphthalen-2-yl-butyric acid hydrochloride (2R,3S)-1d</head><formula xml:id="formula_3">H 2 N CO 2 H Me H H HCl</formula><p>The general procedure was followed using (2R,3S)-7d (250mg, 0.88mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2R,3S)-1d as an off-white solid (158mg, 68%</p><p>). M.p. 200-203°C; ν max (KBr) 1588 (amino acid II), 1770 amino acid I), 1978 (NH 3 + overtones and combinations), 2981 (OH), 3419cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.46 (3H, d J=7.2Hz, CH 3 ), 3.64 (1H, quin. J=6.8Hz, CH), 4.22 (1H, d J=5.4Hz, CH), 7.41-7.91 (7H, m, ArH); m/z (FAB) 230 (MH + ); found (FAB) 230.11857 (MH + ), C 14 H 16 NO 2 requires 230.11810; [α] 22 D -10.0° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 17.12 (100%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.5) Synthesis of (2R,3S)-2-Amino-3-(3,5-dimethylphenyl)butyric acid hydrochloride (2R,3S)-1e</head><p>H 2 N CO 2 H Me H H HCl Me Me The general procedure was followed using (2R,3S)-7e (250mg, 0.95mmol), acetone (2.5ml) and HCl (20.0ml) and trituration with ether yielded (2R,3S)-1e as a white solid (205mg, 89%). M.p. 183-186°C; ν max (KBr) 1607 (amino acid II), 1733 (amino acid I), 2975 (OH), 3435cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.32 (3H, d J=7.4Hz, CH 3 ), 2.21 (6H, s, (CH 3 ) 2 ), 3.38 (1H,quin. J=6.0Hz, CH), 4.03 (1H, d J=5.4Hz, CH), 6.91-6.98 (3H, m, ArH); δ C (63MHz, D 2 O) 15.2 (CH 3 ), 20.8 ((CH 3 ) 2 ), 40.0 (CH), 59.1 (CH), 126.0, 129.8 (C Ar ), 139.7, 171.5 (C); m/z (FAB) 208 (MH + ); found (FAB) 208.13378 (MH + ), C 12 H 18 NO 2 requires 208.13375; [α] 22 D -6.0° (c=1.00, H 2 O) HPLC: Chirobiotic T; R t (min) 10.01 (0.5%), 12.81 (99.5).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.6) Synthesis of (2R,3S)-2-Amino-3-(4-methoxyphenyl)butyric acid hydrochloride (2R,3S)-1f</head><formula xml:id="formula_4">H 2 N CO 2 H Me H H HCl MeO</formula><p>The general procedure was followed using (2R,3S)-7f (250mg, 0.95mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2R,3S)-1f as a white solid (154mg, 66%</p><p>). M.p. 210-213°C; ν max (KBr) 1611 (amino acid II), 1732 (amino acid I), 1942 and 2532 (NH 3 + overtones and combinations), 2988 (OH), 3442cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.35 (3H, d J=7.4Hz, CH 3 ), 3.45 (1H, quin. J=6.4Hz, CH), 4.04 (1H, d J=5.4Hz, CH), 6.95-7.28 (4H, m, ArH); δ C (63Hz, D 2 O) 15.4 (CH 3 ), 39.4 (CH), 55.8 (OCH 3 ), 59.2 (CH), 114.9, 129.5 (C Ar ), 131.9, 158.9, 171.6 (C); m/z (FAB) 210 (MH + ); found (FAB) 210.11298 (MH + ), C 11 H 16 NO 3 requires 210.11302; [α] 22 D -6.0° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 9.83 (0.1%), 11.93 (99.9%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.7) Synthesis of (2S,3R)-2-Amino-3-phenyl-butyric acid hydrochloride (2S,3R)-1a</head><formula xml:id="formula_5">H 2 N CO 2 H Me H H HCl</formula><p>The general procedure was followed using (2S,3R)-7a (250mg,1.06mmol), acetone (2.5ml) and HCl (20ml) and yielded (2S,3R)-1a as a white solid (204mg, 69%</p><p>). M.p. 190-192°C; ν max (nujol) 1603 (amino acid II), 1731 (amino acid I), 1951 and 2535 (NH 3 + overtones and combinations), 2977 (OH), 3437cm -1 (NH 3 + ); δ H (250MHz, D 2 O) 1.23 (3H, d J=7.3Hz, CH 3 ), 3.32 (1H, quin., J=5.9Hz, CH), 4.01 (1H, d J=5.7Hz, CH), 7.12-7.22 (5H, m, ArH); δ C (63MHz, D 2 O) 15.1 (CH 3 ), 40.1 (CH), 59.2 (CH), 128.2, 128.5, 129.6 (C Ar ), 139.5 171.6 (C); m/z (FAB) 180 (MH + ); found (FAB) 180.10256 (MH + ), C 10 H 14 NO 2 requires 180.10245; [α] 22 D +5.0° (c=0.50, H 2 O). HPLC: Chirobiotic T; R t (min) 7.56 (99.9%), 9.99 (0.1%). 4.8) Synthesis of (2S,3R)-2-Amino-3-(4-fluorophenyl)butyric acid hydrochloride (2S,3R)-1b H 2 N CO 2 H Me H H HCl F The general procedure was followed using (2S,3R)-7b (253mg, 1.0mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2S,3R)-1b as a white solid (178mg, 76%). M.p. 186-190°C; ν max (KBr) 1604 (amino acid II), 1732 (amino acid I), 1950 and 2530 (NH 3 + overtones and combinations), 2990 (OH), 3449cm -1 (NH 3 + ); δ H (200MHz, D 2 O) 1.41(3H, d J=7.2Hz, CH 3 ), 3.51 (1H, quin. J=6.2Hz, CH), 4.18 (1H, d J=6.0Hz, CH), 7.08-7.36 (4H, m, ArH); δ C (63MHz, D 2 O) 15.4 (CH 3 ), 39.4 (CH), 59.1 (CH), 116.0, 116.4, 129.9, 130.1 (C Ar ), 135.4, 160.6, 164.5, 171.6 (C); m/z (FAB) 198 (MH + ); found (FAB) 198.09318 (MH + ), C 10 H 13 FNO 2 requires 198.09303; [α] 22 D +4.5° (c=1.00, H 2 O</p><p>). HPLC: Chirobiotic T; R t (min) 7.69 (99.6%), 9.67 (0.4%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>4.9) Synthesis of (2S,3R)-2-Amino-3-(4-trifluoromethylphenyl)butyric acid hydrochloride (2S,3R)-1c</head><formula xml:id="formula_6">H 2 N CO 2 H Me H H HCl F 3 C</formula><p>The general procedure was followed using (2S,3R)-7c (250mg, 0.83mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2S,3R)-1c as a white solid (198mg, 84%</p><p>). M.p. 181-184° C; ν max (KBr) 1622 (amino acid II), 1733 (amino acid I), 2998 (OH), 3443cm -1 (NH 3 + ); δ H (200MHz, D 2 0) 1.40 (3H, d J=6.8Hz, CH 3 ), 3.54 (1H, quin. J=6.2Hz, CH), 4.14 (1H, d J=6.0Hz, CH), 7.43-7.69 (4H, m, ArH); δ C (63MHz, D 2 O) 15.3 (CH 3 ), 40.1 (CH), 58.9 (CH), 126.7, 128.8 (C Ar ), 143.9, 171.3 (C); m/z (FAB) 248 (MH + ); found (FAB) 248.08899 (MH + ), C 11 H 13 F 3 NO 2 requires 248.08984; [α] 22 D +7.0° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 7.51 (100%). 4.10) Synthesis of (2S,3R)-2-Amino-3-naphthalen-2-yl-butyric acid hydrochloride (2S,3R)-1d H 2 N CO 2 H Me H H HCl The general procedure was followed using (2S,3R)-7d (250mg, 0.88mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2S,3R)-1d as an off-white solid (203mg, 87%). M.p. 205-207°C; ν max (KBr) 1588 (amino acid II), 1770 (amino acid I), 1977 (NH 3 + overtones and combinations), 2982 (OH), 3419cm -1 (NH 3 + ); δ H (200MHz, D 2 0) 1.47 (3H, d J=7.2Hz, CH 3 ), 3.66 (1H, quin. J=6.8Hz, CH), 4.19 (1H, d J=5.4Hz, CH), 7.43-7.93 (7H, m, ArH); m/z (FAB) 230 (MH + ); found (FAB) 230.11834 (MH + ), C 14 H 16 NO 2 requires 230.11810; [α] 22 D +10.0° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 8.87 (100%). 4.11) Synthesis of (2S,3R)-2-Amino-3-(3,5-dimethylphenyl)butyric acid hydrochloride (2S,3R)-1e H 2 N CO 2 H Me H H HCl Me Me The general procedure was followed using (2S,3R)-7e (250mg, 0.95mmol), acetone (2.5ml) and HCl (20.0ml) and trituration with ether yielded (2S,3R)-1e as a white solid (170mg, 73%). M.p. 180-185°C; ν max (KBr) 1608 (amino acid II), 1733 (amino acid I), 2975 (OH), 3437cm -1 (NH 3 + ); δ H (200MHz, D 2 0) 1.33 (3H, d J=7.4Hz, CH 3 ), 2.24 (6H, s, (CH 3 ) 2 ), 3.43 (1H, quin. J=6.0Hz, CH), 4.04 (1H, d J=5.4Hz, CH), 6.95-7.00 (3H, m, ArH); δ C (63MHz, D 2 O) 15.2 (CH 3 ), 20.8 ((CH 3 ) 2 ), 40.0 (CH), 59.1 (CH), 126.0, 129.8 (C Ar ), 139.7, 171.5 (C); m/z (FAB) 208 (MH + ); found (FAB) 208.13419 (MH + ), C 12 H 18 NO 2 requires 208.13375; [α] 22 D +4.0° (c=1.00, H 2 O) HPLC: Chirobiotic T; R t (min) 9.15 (99.5%), 14.83 (0.5%). 4.12) Synthesis of (2S,3R)-2-Amino-3-(4-methoxyphenyl)butyric acid hydrochloride (2S,3R)-1f H 2 N CO 2 H Me H H HCl MeO The general procedure was followed using (2S,3R)-7f (250mg, 0.95mmol), acetone (2.5ml) and HCl (20.0ml) and yielded (2S,3R)-1f as a white solid (155mg, 67%). M.p. 211-213°C; ν max (KBr) 1611(amino acid II), 1731 (amino acid I), 1947 and 2535 (NH 3 + overtones and combinations), 2990 (OH), 3442cm -1 (NH 3 + ); δ H (200MHz, D 2 0) 1.35(3H, d J=7.4Hz, CH 3 ), 3.45 (1H, quin. J=6.4Hz, (CH), 114.9, 129.5 (C Ar ), 131.9, 158.9, 171.6 (C); m/z (FAB) 210 (MH + ); found (FAB) 210.11318 (MH + ), C 11 H 16 NO 3 requires 210.11302; [α] 22 D +5.0° (c=1.00, H 2 O). HPLC: Chirobiotic T; R t (min) 9.88 (100%).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5) General procedure for D-AAO stereoinversion</head><p>A mixture of amino acid hydrochloride (2R,3S)-1 (2ml of a 5mM solution), Trigonopsis variabilis D-amino acid oxidase (5 drops of immobilised slurry, 222.7 U/g dry weight) and ammonia-borane complex (5mg, 0.16mmol) were shaken on a blood rotator at 30°C. Samples were filtered and analysed by HPC at t=0 and t=20hr.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.1) Synthesis of (2S,3S)-2-Amino-3-phenyl-butyric acid (2S,3S)-1a</head><formula xml:id="formula_7">H 2 N CO 2 H Me H H</formula><p>The general procedure was followed using (2R,3S)-1a.</p><p>HPLC: Chirobiotic T; R t (min): t=0hr 6.60 (0.2%), 8.82 (99.8%); t=20hr 6.40 (99.9%), 8.94 (0.1%); 69% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.2) Synthesis of (2S,3S)-2-Amino-3-(4-fluorophenyl)butyric acid (2S,3S)-1b</head><formula xml:id="formula_8">H 2 N CO 2 H Me H H F</formula><p>The general procedure was followed using (2R,3S)-1b.</p><p>HPLC: Chirobiotic T; R t (min): t=0hr 8.25 (100%); t=20hr 6.33 (100%); 68% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.3) Synthesis of (2S,3S)-2-Amino-3-(4-trifluoromethylphenyl)butyric acid (2S,3S)-1c</head><formula xml:id="formula_9">H 2 N CO 2 H Me H H F 3 C</formula><p>The general procedure was followed using (2R,3S)-1c.</p><p>HPLC: Chirobiotic T; R t (min): t=0hr 6.30 (1%), 7.82 (99%); t=20hr 6.05 (100%); 81% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.4) Synthesis of (2S,3S</head><p>)-2-Amino-3-naphthalen-2-yl-butyric acid (2S,3S)-1d</p><formula xml:id="formula_10">H 2 N CO 2 H Me H H</formula><p>The general procedure was followed using (2R,3S)-1d.</p><p>HPLC: Chirobiotic T; R t (min): t=0hr 8.02 (1.9%), 13.02 (98.1%); t=20hr 7.83 (100%); 80% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.5) Synthesis of (2S,3S</head><p>)-2-Amino-3-(3,5-dimethylphenyl)butyric acid (2S,3S)-1e</p><formula xml:id="formula_11">H 2 N CO 2 H Me H H Me Me</formula><p>The general procedure was followed using (2R,3S)-1e.</p><p>HPLC: Chirobiotic T; R t (min) t=0hr 6.73 (2.8%), 10.44 (97.2%); t=20hr 6.53 (100%); 72% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5.6) Synthesis of (2S,3S)-2-Amino-3-(4-methoxyphenyl)butyric acid (2S,3S)-1f</head><formula xml:id="formula_12">H 2 N CO 2 H Me H H MeO</formula><p>The general procedure was followed using (2R,3S)-1f.</p><p>HPLC: Chirobiotic T; R t (min): t=0hr 6.99 (0.2%), 9.13 (99.8%); t=20hr 6.76 (100%); 81% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6) General procedure for L-AAO stereoinversion</head><p>A mixure of amino acid hydrochloride (2S,3R)-1 (4ml of a 5mM solution), Snake venom L-amino acid oxidase (20mg of a 0.5U/mg enzyme) and ammonia-borane complex (10mg, 0.32mmol) were shaken on a blood rotator at 30°C.</p><p>Samples were filtered and analysed by HPLC at t=0 and t=20hr.</p><p>6.1) 6.1 Synthesis of (2R,3R)-2-Amino-3-phenyl-butyric acid (2R,3R)-1a</p><formula xml:id="formula_13">H 2 N CO 2 H Me H H</formula><p>The general procedure was followed using (2S,3R)-1a.</p><p>HPLC: Chirobiotic T; R t (min): t =0hr 7.00 (100%); t=20hr 8.88 (100%); 83% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6.</head><p>2) Synthesis of (2R,3R)-2-Amino-3-(4-fluorophenyl)butyric acid (2R,3R)-1b</p><formula xml:id="formula_14">H 2 N CO 2 H Me H H F</formula><p>The general procedure was followed using (2S,3R)-1b.</p><p>HPLC: Chirobiotic T; R t (min): t =0hr 6.79 (100%); t=20hr 8.69 (100%); 85% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6.</head><p>3) Synthesis of (2R,3R)-2-Amino-3-(4-trifluoromethylphenyl)butyric acid (2R,3R)-1c</p><formula xml:id="formula_15">H 2 N CO 2 H Me H H F 3 C</formula><p>The general procedure was followed using (2S,3R)-1c.</p><p>HPLC: Chirobiotic T; R t (min): t =0hr 6.48 (100%); t=20hr 7.94 (100%); 92% yield; &gt;99% d.e.</p><p>6.4) Synthesis of (2R,3R)-2-Amino-3-naphthalen-2-yl-butyric acid (2R,3R)-1d</p><p>H 2 N CO 2 H Me H H The general procedure was followed using (2S,3R)-1d. HPLC: Chirobiotic T; R t (min): t =0hr 9.08 (100%); t=20hr 9.82 (1.2%), 11.96 (98.8%); t=40hr 12.50 (100%); 80% yield; &gt;99% d.e. 6.5) Synthesis of (2R,3R)-2-Amino-3-(3,5-dimethylphenyl)butyric acid (2R,3R)-1e H 2 N CO 2 H Me H H Me Me The general procedure was followed using (2S,3R)-1e. HPLC: Chirobiotic T; R t (min): t =0hr 7.28 (100%); t=20hr 7.28 (52.8%), 8.26 (47.2%); t=40hr 7.43 (32.6%), 8.41 (67.4%); t=64hr 7.36 (25.5%), 8.27 (74.5%); 71% yield, 49% d.e. 6.6) Synthesis of (2R,3R)-2-Amino-3-(4-methoxyphenyl)butyric acid (2R,3R)-1f H 2 N CO 2 H Me H H MeO</p><p>The general procedure was followed using (2S,3R)-1f.</p><p>HPLC: Chirobiotic T; R t (min): t =0hr 7.56 (100%), t=20hr 7.71 (2.7%), 9.95 (97.3%); t=40hr 10.13 (100%); 80% yield; &gt;99% d.e.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>7) Stereoinversion on 1g scale</head><p>A mixture of β-methylphenylalanine hydrochloride (2R,3R)-1a (1.00g, 4.64mmol), ammonia-borane complex (3.10g, 100mmol), T. variabilis D-AAO (10ml of immobilised slurry, 222.7 U/g dry weight) in water (200ml) was shaken at 37°C for 96hr. HPLC showed complete conversion with 54% yield. The mixture was filtered and freeze dried, taken up in boiling ethanol and hot filtered to remove unreacted ammonia-borane. Recrystallisation from ethanol/ethyl acetate gave (2S,3R)-1a as a white solid (455mg 55%</p><p>). M.p. 188°C decomp.; δ H (250MHz, D 2 O) 1.41 (3H, d J=7.3Hz, CH 3 ), 3.55 (1H, quin. J=7.3Hz, CH), 3.93 (1H, d J=5.0Hz, CH), 7.32-7.45 (5H, m, ArH); δ C (63MHz, D 2 O) 14.2 (CH 3 ), 39.9 (CH), 61.1 (CH), 128.2, 129.5 (C Ar ), 140.7, 173.8 (C); m/z (ES+) 180 (MH + ); [α] 20 D 4.2° (c=0.83, CHCl 3 ). HPLC: Chirobiotic T; R t (min): t=0hr 10.33 (100%), t=96hr 8.46 (100%).</p></div>		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
